Works matching AU Han, Hyo S

Results: 23
    1

    Phase II trial of brain MRI surveillance in stage IV breast cancer.

    Published in:
    Neuro-Oncology, 2025, v. 27, n. 6, p. 1550, doi. 10.1093/neuonc/noaf018
    By:
    • Ahmed, Kamran A;
    • Kim, Youngchul;
    • Armaghani, Avan J;
    • Arrington, John A;
    • Costa, Ricardo L;
    • Czerniecki, Brian J;
    • Diaz, Roberto;
    • Dowell, Robin A;
    • Extermann, Martine;
    • Forsyth, Peter A;
    • Lee, Kimberley T;
    • Loftus, Loretta;
    • Mills, Matthew N;
    • Phuoc, Vania H;
    • Rosa, Marilin;
    • Soliman, Hatem H;
    • Sam, Christine S;
    • Washington, Iman R;
    • Soyano, Aixa E;
    • Han, Hyo S
    Publication type:
    Article
    2
    3
    4
    5

    CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 583, doi. 10.1007/s11060-019-03260-6
    By:
    • Figura, Nicholas B.;
    • Potluri, Thrisha K.;
    • Mohammadi, Homan;
    • Oliver, Daniel E.;
    • Arrington, John A.;
    • Robinson, Timothy J.;
    • Etame, Arnold B.;
    • Tran, Nam D.;
    • Liu, James K.;
    • Soliman, Hatem;
    • Forsyth, Peter A.;
    • Sahebjam, Solmaz;
    • Yu, H. Michael;
    • Han, Hyo S.;
    • Ahmed, Kamran A.
    Publication type:
    Article
    6

    Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00711-w
    By:
    • Khatri, Vaseem M.;
    • Mestres-Villanueva, Mariella A.;
    • Yarlagadda, Sreenija;
    • Doniparthi, Ajay;
    • Smith, David B.;
    • Nakashima, Justyn Y.;
    • Bryant, John M.;
    • Zhao, Dekuang;
    • Upadhyay, Rituraj;
    • Mills, Matthew N.;
    • Oliver, Daniel E.;
    • Yu, Hsiang-Hsuan Michael;
    • Palmer, Joshua D.;
    • Williams, Nicole O.;
    • Mahtani, Reshma L.;
    • Ahluwalia, Manmeet S.;
    • Soliman, Hatem H.;
    • Han, Hyo S.;
    • Soyano, Aixa E.;
    • Kim, Youngchul
    Publication type:
    Article
    7

    Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00493-z
    By:
    • Lang, Julie E.;
    • Forero-Torres, Andres;
    • Yee, Douglas;
    • Yau, Christina;
    • Wolf, Denise;
    • Park, John;
    • Parker, Barbara A.;
    • Chien, A. Jo;
    • Wallace, Anne M.;
    • Murthy, Rashmi;
    • Albain, Kathy S.;
    • Ellis, Erin D.;
    • Beckwith, Heather;
    • Haley, Barbara B.;
    • Elias, Anthony D.;
    • Boughey, Judy C.;
    • Yung, Rachel L.;
    • Isaacs, Claudine;
    • Clark, Amy S.;
    • Han, Hyo S.
    Publication type:
    Article
    8

    Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059601
    By:
    • Ayoub, Jean-Pierre;
    • Wildiers, Hans;
    • Friedlander, Michael;
    • Arun, Banu K.;
    • Han, Hyo S.;
    • Puhalla, Shannon;
    • Shparyk, Yaroslav;
    • Jakobsen, Erik H.;
    • Wu, Meijing;
    • Bach, Bruce A.;
    • Feng, Dai;
    • Ratajczak, Christine K.;
    • Maag, David;
    • Diéras, Véronique
    Publication type:
    Article
    9

    Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059601
    By:
    • Ayoub, Jean-Pierre;
    • Wildiers, Hans;
    • Friedlander, Michael;
    • Arun, Banu K.;
    • Han, Hyo S.;
    • Puhalla, Shannon;
    • Shparyk, Yaroslav;
    • Jakobsen, Erik H.;
    • Wu, Meijing;
    • Bach, Bruce A.;
    • Feng, Dai;
    • Ratajczak, Christine K.;
    • Maag, David;
    • Diéras, Véronique
    Publication type:
    Article
    10
    11
    12

    Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 21, p. 7665, doi. 10.1002/cam4.4295
    By:
    • Sun, James;
    • Zhong, Xiaojun;
    • Ma, Junjie;
    • Sun, Weihong;
    • Han, Hyo S.;
    • Soliman, Hatem H.;
    • Loftus, Loretta S.;
    • Costa, Ricardo L. B.;
    • Armaghani, Avan J.;
    • Soyano‐Muller, Aixa E.;
    • Czerniecki, Brian J.;
    • Lee, M. Catherine;
    • Kiluk, John V.;
    • Khakpour, Nazanin;
    • Hoover, Susan J.;
    • Laronga, Christine;
    • Khong, Hung T.
    Publication type:
    Article
    13
    14

    Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 3, p. 487, doi. 10.1007/s10549-024-07555-9
    By:
    • Rugo, Hope S.;
    • Campbell, Mike;
    • Yau, Christina;
    • Jo Chien, A.;
    • Wallace, Anne M.;
    • Isaacs, Claudine;
    • Boughey, Judy C.;
    • Han, Hyo S.;
    • Buxton, Meredith;
    • Clennell, Julia L.;
    • Asare, Smita M.;
    • Steeg, Katherine;
    • Wilson, Amy;
    • Singhrao, Ruby;
    • Matthews, Jeffrey B.;
    • Perlmutter, Jane;
    • Fraser Symmans, W.;
    • Hylton, Nola M.;
    • DeMichele, Angela M.;
    • Yee, Douglas
    Publication type:
    Article
    15

    Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 383, doi. 10.1007/s10549-022-06803-0
    By:
    • Magbanua, Mark Jesus M.;
    • van 't Veer, Laura;
    • Clark, Amy S.;
    • Chien, A. Jo;
    • Boughey, Judy C.;
    • Han, Hyo S.;
    • Wallace, Anne;
    • Beckwith, Heather;
    • Liu, Minetta C.;
    • Yau, Christina;
    • Wileyto, E. Paul;
    • Ordonez, Andrea;
    • Solanki, Tulasi I.;
    • Hsiao, Feng;
    • Lee, Jen Chieh;
    • Basu, Amrita;
    • Brown Swigart, Lamorna;
    • Perlmutter, Jane;
    • Delson, Amy L.;
    • Bayne, Lauren
    Publication type:
    Article
    16

    The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 209, doi. 10.1007/s10549-021-06420-3
    By:
    • Mills, Matthew N.;
    • Potluri, Thrisha K.;
    • Kawahara, Yuki;
    • Fahey, Matthew;
    • Figura, Nicholas B.;
    • Soyano, Aixa E.;
    • Washington, Iman R.;
    • Diaz, Roberto;
    • Oliver, Daniel E.;
    • Yu, Hsiang-Hsuan Michael;
    • Etame, Arnold B.;
    • Vogelbaum, Michael A.;
    • Czerniecki, Brian J.;
    • Arrington, John A.;
    • Sahebjam, Solmaz;
    • Forsyth, Peter A.;
    • Soliman, Hatem H.;
    • Han, Hyo S.;
    • Ahmed, Kamran A.
    Publication type:
    Article
    17
    18
    19

    Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.

    Published in:
    Breast Cancer Research & Treatment, 2019, v. 175, n. 3, p. 781, doi. 10.1007/s10549-019-05170-7
    By:
    • Figura, Nicholas B.;
    • Rizk, Victoria T.;
    • Mohammadi, Homan;
    • Evernden, Brittany;
    • Mokhtari, Sepideh;
    • Yu, H. Michael;
    • Robinson, Timothy J.;
    • Etame, Arnold B.;
    • Tran, Nam D.;
    • Liu, James;
    • Washington, Iman;
    • Diaz, Roberto;
    • Czerniecki, Brian J.;
    • Soliman, Hatem;
    • Han, Hyo S.;
    • Sahebjam, Solmaz;
    • Forsyth, Peter A.;
    • Ahmed, Kamran A.
    Publication type:
    Article
    20
    21
    22

    Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26019-y
    By:
    • Clark, Amy S.;
    • Yau, Christina;
    • Wolf, Denise M.;
    • Petricoin, Emanuel F.;
    • van 't Veer, Laura J.;
    • Yee, Douglas;
    • Moulder, Stacy L.;
    • Wallace, Anne M.;
    • Chien, A. Jo;
    • Isaacs, Claudine;
    • Boughey, Judy C.;
    • Albain, Kathy S.;
    • Kemmer, Kathleen;
    • Haley, Barbara B.;
    • Han, Hyo S.;
    • Forero-Torres, Andres;
    • Elias, Anthony;
    • Lang, Julie E.;
    • Ellis, Erin D.;
    • Yung, Rachel
    Publication type:
    Article
    23

    Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 12, p. e2349646, doi. 10.1001/jamanetworkopen.2023.49646
    By:
    • Kyalwazi, Beverly;
    • Yau, Christina;
    • Campbell, Michael J.;
    • Yoshimatsu, Toshio F.;
    • Chien, A. Jo;
    • Wallace, Anne M.;
    • Forero-Torres, Andres;
    • Pusztai, Lajos;
    • Ellis, Erin D.;
    • Albain, Kathy S.;
    • Blaes, Anne H.;
    • Haley, Barbara B.;
    • Boughey, Judy C.;
    • Elias, Anthony D.;
    • Clark, Amy S.;
    • Isaacs, Claudine J.;
    • Nanda, Rita;
    • Han, Hyo S.;
    • Yung, Rachel L.;
    • Tripathy, Debasish
    Publication type:
    Article